ドライパウダー吸入器の世界市場レポート 2024年

ドライパウダー吸入器の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には5.0%の年間複合成長率（CAGR）で258億2,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、持続可能性、世界の都市化動向、製造プロセスの進歩、持続可能な建設を支援する政府の奨励金と政策、および世界の経済要因の継続的な重視に起因すると考えられます。予測期間中に予想される主な動向としては、建設業界における研究開発の増加、伝統的な建築技術への新たな関心、材料技術の進歩、建築およびデザインの動向の進化、持続可能な建設実践に対する規制の支援などが挙げられます。

呼吸器疾患の有病率の増加が予想されるため、将来のドライパウダー吸入器市場の成長を促進する態勢が整っています。呼吸器疾患には呼吸器系に影響を与える幅広い病状が含まれており、ドライパウダー吸入器は喘息、COPD、嚢胞性線維症などの病状の治療において重要な役割を果たします。これらの吸入器は薬剤を肺に直接送達するため、呼吸器疾患に対する従来のドラッグデリバリー方法に代わる有望な代替手段となります。たとえば、オーストラリア保健福祉研究所の2023年6月の報告書では、オーストラリアにおける呼吸器疾患関連死亡者数が2020年の4万3,031人から2021年には4万6,551人に増加したことが示されています。したがって、呼吸器疾患の有病率の増加により、ドライパウダー吸入器市場の成長が促進されると予想されます。

大気汚染レベルの増加も、ドライパウダー吸入器市場の成長に寄与すると予想されます。大気中のさまざまな汚染物質の濃度によって測定される大気汚染は、呼吸器系の問題を引き起こすため、ドライパウダー吸入器は、症状を軽減し、空気中の汚染物質によって悪化する呼吸器症状を管理する薬剤の好ましい投与方法となっています。 2022年に米国環境保護庁は、米国の大気中に放出された汚染物質が約6,600万トンであると報告しました。さらに、2023年3月、IQAirは、イラクが2022年のWHOのPM2.5年間ガイドラインの16倍にあたる80.1μg/m3で2番目に汚染の多い国であると報告しました。 大気汚染の増加が、ドライパウダー吸入器市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のドライパウダー吸入器市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界のドライパウダー吸入器の市場規模実績と成長、2018年～2023年
• 世界のドライパウダー吸入器市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のドライパウダー吸入器市場、製品別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 単回投与吸入器
• 複数回投与吸入器
• 世界のドライパウダー吸入器市場、機能別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 手動吸入器
• デジタル操作の吸入装置
• 世界のドライパウダー吸入器市場、用途別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 喘息
• 慢性閉塞性肺疾患（COPD）
• 嚢胞性線維症
• その他の用途
• 世界のドライパウダー吸入器市場、エンドユーザー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 病院と診療所
• ホームケア設定
• 外来手術センター
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のドライパウダー吸入器市場、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
• 世界のドライパウダー吸入器市場、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドライパウダー吸入器市場の競合情勢
• ドライパウダー吸入器市場の企業プロファイル
  • Novartis AG
  • AstraZeneca plc.
  • GlaxoSmithKline Plc
  • 3M Company
  • Boehringer Ingelheim GmbH

第31章 その他の主要および革新的な企業

• Viatris（Mylan NV）
• Otsuka Pharmaceutical Co. Ltd
• Sun Pharmaceutical Industries Limited
• Catalent Inc.
• Aptar Group Inc.
• Chiesi Farmaceutici SpA
• Recipharm AB
• Cipla Limited
• Lupin Limited
• Orion Corporation
• OPKO Health
• Zhejiang Hisun Pharmaceutical Co Ltd
• Beximco Pharmaceuticals Ltd
• Sava Healthcare Ltd.
• Hovione

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

A dry powder inhaler (DPI) is a medical device designed for delivering medication in the form of dry powder directly to the lungs. It is primarily used for treating respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). To effectively use a DPI, it is crucial for the user to inhale rapidly and deeply, allowing the medication to reach the lungs.

The main types of dry powder inhalers include single-dose inhalers and multi-dose inhalers. Single-dose inhalers are devices that administer medication directly to the lungs in the form of dry powder. These devices can be either manually operated or digitally operated, and they find applications in treating conditions such as asthma, COPD, cystic fibrosis, and others. Various end-users, including hospitals and clinics, homecare settings, and ambulatory surgical centers, utilize these inhalers.

The dry powder inhaler market research report is one of a series of new reports from The Business Research Company that provides dry powder inhaler market statistics, including dry powder inhaler industry global market size, regional shares, competitors with a dry powder inhaler market share, detailed dry powder inhaler market segments, market trends and opportunities, and any further data you may need to thrive in the dry powder inhaler industry. This dry powder inhaler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry powder inhaler market size has grown strongly in recent years. It will grow from $20.18 billion in 2023 to $21.25 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth observed in the historical period can be attributed to factors such as renewed interest in sustainable building materials, cultural preservation and heritage restoration, the rise in green building practices, local sourcing, community involvement, and regulatory support including building codes.

The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $25.82 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The anticipated growth in the forecast period can be attributed to continued emphasis on sustainability, global urbanization trends, advancements in manufacturing processes, government incentives and policies supporting sustainable construction, and global economic factors. Major trends expected in the forecast period include increased research and development in the construction industry, renewed interest in traditional building techniques, advancements in material technology, evolving architectural and design trends, and regulatory support for sustainable construction practices.

The anticipated increase in the prevalence of respiratory diseases is poised to drive the growth of the dry powder inhaler market in the future. Respiratory diseases encompass a wide range of medical conditions affecting the respiratory system, and dry powder inhalers play a crucial role in treating conditions such as asthma, COPD, and cystic fibrosis. These inhalers deliver medication directly to the lungs, offering a promising alternative to traditional drug delivery methods for respiratory diseases. For example, reports from the Australian Institute of Health and Welfare in June 2023 indicated a rise in respiratory disease-related deaths from 43,031 in 2020 to 46,551 in 2021 in Australia. Thus, the growing prevalence of respiratory diseases is expected to propel the growth of the dry powder inhaler market.

The increasing levels of air pollution are also anticipated to contribute to the growth of the dry powder inhaler market. Air pollution, measured by the concentration of various pollutants in the atmosphere, leads to respiratory issues, making dry powder inhalers a preferred delivery method for medications that alleviate symptoms and manage respiratory conditions exacerbated by airborne pollutants. In 2022, the United States Environmental Protection Agency reported approximately 66 million tons of pollutants released into the atmosphere in the United States. Additionally, in March 2023, IQAir reported that Iraq was the second most polluted country with 80.1 µg/m3, 16 times higher than the WHO PM2.5 annual guideline in 2022. Therefore, the rising levels of air pollution are expected to drive the growth of the dry powder inhaler market.

The stringent regulatory guidelines are anticipated to pose challenges to the growth of the dry powder inhaler market. The imposition of rigorous testing and compliance requirements has increased the hurdles for product development, usage, and market entry. In September 2023, The Scottish Government released a consultation draft guidance on quality prescribing for respiratory illness, emphasizing the importance of effective use of dry powder inhalers (DPIs) and providing information on inhaler choice and technique. Strict regulatory guidelines may impede the growth of the dry powder inhaler market.

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and expanding their product portfolios. Muscarinic antagonists are drugs that inhibit the muscarinic acetylcholine receptor and are used to treat various illnesses, including COPD. For instance, Glenmark Pharmaceuticals Limited launched Tiogiva, a long-acting muscarinic antagonist dry powder inhaler (DPI) for COPD treatment in the UK in June 2021. The DPI functions by relaxing the muscles in the airways, facilitating breathing and requiring only once-a-day usage.

In February 2021, Catalent Inc. acquired Acorda Therapeutics Inc., expanding its capabilities in DPI manufacturing and adding a commercial-stage product to its portfolio, emphasizing the growing significance of DPI therapies for respiratory and neurological diseases. Acorda Therapeutics Inc. produces various DPIs for patients with respiratory diseases.

Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

North America was the largest region in the dry powder inhaler market in 2023. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Dry Powder Inhaler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dry powder inhaler market consists of sales of dry powder forms, spiriva handihalers, breath-activated inhalers, rotahalers, diskus devices, and twisthaler inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Powder Inhaler Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry powder inhaler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry powder inhaler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dry powder inhaler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Single-Dose Inhalers; Multi-Dose Inhalers
• 2) By Function: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
• 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Other Applications
• 4) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
• Companies Mentioned: Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Boehringer Ingelheim GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Powder Inhaler Market Characteristics

3. Dry Powder Inhaler Market Trends And Strategies

4. Dry Powder Inhaler Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Dry Powder Inhaler Market Size and Growth

• 5.1. Global Dry Powder Inhaler Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Dry Powder Inhaler Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Dry Powder Inhaler Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Dry Powder Inhaler Market Segmentation

• 6.1. Global Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Single-Dose Inhalers
• Multi-Dose Inhalers
• 6.2. Global Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices
• 6.3. Global Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Cystic Fibrosis
• Other Applications
• 6.4. Global Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals And Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Other End Users

7. Dry Powder Inhaler Market Regional And Country Analysis

• 7.1. Global Dry Powder Inhaler Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Dry Powder Inhaler Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Dry Powder Inhaler Market

• 8.1. Asia-Pacific Dry Powder Inhaler Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Dry Powder Inhaler Market

• 9.1. China Dry Powder Inhaler Market Overview
• 9.2. China Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Dry Powder Inhaler Market

• 10.1. India Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Dry Powder Inhaler Market

• 11.1. Japan Dry Powder Inhaler Market Overview
• 11.2. Japan Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Dry Powder Inhaler Market

• 12.1. Australia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Dry Powder Inhaler Market

• 13.1. Indonesia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Dry Powder Inhaler Market

• 14.1. South Korea Dry Powder Inhaler Market Overview
• 14.2. South Korea Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Dry Powder Inhaler Market

• 15.1. Western Europe Dry Powder Inhaler Market Overview
• 15.2. Western Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Dry Powder Inhaler Market

• 16.1. UK Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Dry Powder Inhaler Market

• 17.1. Germany Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Dry Powder Inhaler Market

• 18.1. France Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Dry Powder Inhaler Market

• 19.1. Italy Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Dry Powder Inhaler Market

• 20.1. Spain Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Dry Powder Inhaler Market

• 21.1. Eastern Europe Dry Powder Inhaler Market Overview
• 21.2. Eastern Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Dry Powder Inhaler Market

• 22.1. Russia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Dry Powder Inhaler Market

• 23.1. North America Dry Powder Inhaler Market Overview
• 23.2. North America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Dry Powder Inhaler Market

• 24.1. USA Dry Powder Inhaler Market Overview
• 24.2. USA Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Dry Powder Inhaler Market

• 25.1. Canada Dry Powder Inhaler Market Overview
• 25.2. Canada Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Dry Powder Inhaler Market

• 26.1. South America Dry Powder Inhaler Market Overview
• 26.2. South America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Dry Powder Inhaler Market

• 27.1. Brazil Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Dry Powder Inhaler Market

• 28.1. Middle East Dry Powder Inhaler Market Overview
• 28.2. Middle East Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Dry Powder Inhaler Market

• 29.1. Africa Dry Powder Inhaler Market Overview
• 29.2. Africa Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Dry Powder Inhaler Market Competitive Landscape And Company Profiles

• 30.1. Dry Powder Inhaler Market Competitive Landscape
• 30.2. Dry Powder Inhaler Market Company Profiles
  • 30.2.1. Novartis AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AstraZeneca plc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. GlaxoSmithKline Plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. 3M Company
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Boehringer Ingelheim GmbH
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Dry Powder Inhaler Market Other Major And Innovative Companies

• 31.1. Viatris (Mylan N.V)
• 31.2. Otsuka Pharmaceutical Co. Ltd
• 31.3. Sun Pharmaceutical Industries Limited
• 31.4. Catalent Inc.
• 31.5. Aptar Group Inc.
• 31.6. Chiesi Farmaceutici S.p.A.
• 31.7. Recipharm AB
• 31.8. Cipla Limited
• 31.9. Lupin Limited
• 31.10. Orion Corporation
• 31.11. OPKO Health
• 31.12. Zhejiang Hisun Pharmaceutical Co Ltd
• 31.13. Beximco Pharmaceuticals Ltd
• 31.14. Sava Healthcare Ltd.
• 31.15. Hovione

32. Global Dry Powder Inhaler Market Competitive Benchmarking

33. Global Dry Powder Inhaler Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

35. Dry Powder Inhaler Market Future Outlook and Potential Analysis

• 35.1 Dry Powder Inhaler Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Dry Powder Inhaler Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Dry Powder Inhaler Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer